Simon Mundy

Moral Money Editor

AS SEEN ON

Preston's Summary

Simon Mundy is the Moral Money Editor for the Financial Times, specializing in sustainable finance and ESG (Environmental, Social, and Governance) issues. His articles explore the intersection of finance, ethics, and sustainability, offering insights into the evolving landscape of responsible investing and its impact on the global economy. Simon's work has also been featured in Classical Music and Yahoo Finance.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Expert Commentary: 21 %
Event Coverage: 14 %
Government Announcement: 11 %
Legal Policy Regulation: 11 %
Opinion Editorial: 7 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Investing
  • Environment
  • Sustainability
  • Climate Change
  • Corporate Responsibility

Pitching Insights

Simon Mundy's coverage primarily focuses on the intersection of finance, economy, and environmental themes. He often includes expert commentary, government announcements, and legal policy regulation in his articles. Given this focus, he would likely be interested in receiving pitches from experts who can provide insights into sustainable investing strategies, climate change policies' impact on the economy or corporate responsibility practices.

Pitches should emphasize expertise in sustainable investing practices or knowledge of climate change policies' economic implications to align with Simon's coverage areas. Furthermore, sources with a global perspective on these topics would likely resonate well with Simon's international audience.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Jonathan Moules
Newsletters editor and writer
Publications
Most recent topics
Not enough data
Jamie Smyth
US Pharmaceutical Correspondent
Most recent topics
Not enough data
Most recent topics
Not enough data